SalMeterol Xinafoate Adduct IMpurity
|
|
|
- CAS-Nr.
- 1330076-52-2
- Englisch Name:
- SalMeterol Xinafoate Adduct IMpurity
- Synonyma:
- Salmeterol USP RC H;SalMeterol IMpurity H;Salmeterol Impurity 14;Salmeterol EP Impurity H;salmeterol impurities1071;SalMeterol Related CoMpound H;Salmeterol USP Related Compound H;SalMeterol Xinafoate Adduct IMpurity;Salmeterol Impurity (Xinafoate Adduct Impurity);SalMeterol Xinafoate Adduct IMpurity DISCONTINUED
- CBNumber:
- CB32545735
- Summenformel:
- C36H43NO6
- Molgewicht:
- 585.73
- MOL-Datei:
- 1330076-52-2.mol
|
SalMeterol Xinafoate Adduct IMpurity Eigenschaften
- Siedepunkt:
- 801.1±65.0 °C(Predicted)
- Dichte
- 1.209±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- Aggregatzustand
- solid
- pka
- 3.02±0.30(Predicted)
- Major Application
- pharmaceutical
pharmaceutical small molecule
- InChIKey
- RQBBDIIWJKBGAP-UHFFFAOYSA-N
- SMILES
- N(CC(O)c2cc(c(cc2)O)Cc3c4c(c(c(c3)C(=O)O)O)cccc4)CCCCCCOCCCCc1ccccc1
Sicherheit
| WGK Germany |
3 |
|
|
| HS Code |
2922504500 |
|
|
| Speicherklasse |
11 - Combustible Solids |
|
|
SalMeterol Xinafoate Adduct IMpurity Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Salmeterol Xinafoate (S090100) impurity.
SalMeterol Xinafoate Adduct IMpurity Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
SalMeterol Xinafoate Adduct IMpurity Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 55)Lieferanten
1330076-52-2()Verwandte Suche:
- 1-Hydroxy-4-[[2-hydroxy-5-[1-hydroxy-2-[[6-(4-phenylbutoxy)hexyl]amino]ethyl]phenyl]methyl]-2-naphthalenecarboxylic acid
- 1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid
- Salmeterol Related Compound H (15 mg) (1-hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid)
- Salmeterol USP RC H
- SalMeterol Xinafoate Adduct IMpurity
- SalMeterol Xinafoate Adduct IMpurity DISCONTINUED
- SalMeterol Related CoMpound H
- 1-Hydroxy-4-(2-hydroxy-5-{1-hydroxy-2-[6-(4-phenylbutoxy)hexylaMino]ethyl}benzyl)naphthalene-2-carboxylic Acid
- SalMeterol IMpurity H
- Salmeterol Impurity 9（Salmeterol Related Compound H）
- 1-hydroxy-4-[[2-hydroxy-5-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenyl]methyl]naphthalene-2-carboxylic acid
- Salmeterol Impurity 14
- Salmeterol Impurity H
(Xinafoate Adduct Impurity)
- Salmeterol USP Related Compound H
- 2-Naphthalenecarboxylic acid, 1-hydroxy-4-[[2-hydroxy-5-[1-hydroxy-2-[[6-(4-phenylbutoxy)hexyl]amino]ethyl]phenyl]methyl]-
- Salmeterol Impurity 14 (Xinafoate Adduct Impurity)
- Salmeterol Related Compound H (Salmeterol Xinafoate Adduct Impurity)
- salmeterol impurities1071
- Salmeterol Related Compound H (1-hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amin (1609680)
- Salmeterol Impurity 13 (Xinafoate Adduct Impurity)
- Salmeterol Impurity (Xinafoate Adduct Impurity)
- Salmeterol EP Impurity H
- 1330076-52-2
- Amines
- Aromatics
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Impurity
